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Myosin A (MyoA) is a Class XIVmyosin implicated in gliding
motility and host cell and tissue invasion by malaria parasites.
MyoA is part of a membrane-associated protein complex called
the glideosome, which is essential for parasite motility and
includes the MyoA light chain myosin tail domain–interacting
protein (MTIP) and several glideosome-associated proteins
(GAPs). However, most studies of MyoA have focused on single
stages of the parasite life cycle. We examined MyoA expression
throughout the Plasmodium berghei life cycle in both mamma-
lian and insect hosts. In extracellular ookinetes, sporozoites,
and merozoites, MyoA was located at the parasite periphery.
In the sexual stages, zygote formation and initial ookinete dif-
ferentiation precede MyoA synthesis and deposition, which
occurred only in the developing protuberance. In developing
intracellular asexual blood stages, MyoA was synthesized in
mature schizonts and was located at the periphery of segment-
ing merozoites, where it remained throughout maturation,
merozoite egress, and host cell invasion. Besides the known
GAPs in the malaria parasite, the complex included GAP40, an
additional myosin light chain designated essential light chain
(ELC), and several other candidate components. This ELC
bound theMyoAneck region adjacent to theMTIP-binding site,
and both myosin light chains co-located to the glideosome. Co-
expression of MyoA with its two light chains revealed that the
presence of both light chains enhances MyoA-dependent actin
motility. In conclusion, we have established a system to study
the interplay and function of the three glideosome components,
enabling the assessment of inhibitors that target this motor
complex to block host cell invasion.
Three stages of the malaria parasite, sporozoites, ookinetes,
and merozoites, are invasive to host cells or tissue, and two
stages, sporozoites and ookinetes, aremotile.Motility and inva-
sion are active processes, and in Plasmodium as in other api-
complexan parasites, such as Toxoplasma gondii, an actomyo-
sin motor is central to these processes (reviewed in Refs. 1 and
2).Myosin proteins are typically composed of a conserved glob-
ular head domain, a neck domain comprising variable numbers
of myosin light chain-binding sites, and a diverse tail domain
that is often responsible for dimerization and/or cargo binding.
The myosin head binds to actin and also contains the motor
activity, where ATP hydrolysis is translated into molecular
movement (3–6).MyosinA (MyoA),8 anApicomplexa-specific
class XIV myosin composed of a head and neck region, but
lacking a tail domain, is the motor component of the glideo-
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some protein complex that is attached to the inner membrane
complex (IMC), a network of large, flattened vesicles located
just below the surface plasma membrane of the parasite (7–9).
Some components of the glideosome have been defined in
T. gondii and also in Plasmodium species. In addition toMyoA,
there is a myosin light chain (MLC) that binds to the last few
amino acid residues of MyoA, corresponding to part of the
myosin neck region and called T. gondiiMLC1 (10), or myosin
tail domain–interacting protein (MTIP) in Plasmodium sp.
(11). ThisMLC is involved in anchoringMyoA to the IMC via a
palmitoyl modification (12) and thus appears to take on a role
usually fulfilled by a myosin tail (i.e. anchoring myosin at a
specific subcellular location). Recently, two more T. gondii
MyoA MLCs have been described and named essential light
chains 1 and 2 (ELC1 and -2). The terminology follows that
used for mammalian muscle myosins with two light chains in
which themost proximal is an ELC and the distal is a regulatory
light chain (RLC). ELC1 and -2 have been shown to bind to the
MyoA neck adjacent to MLC1 (which binds at the RLC site) in
amutually exclusivemanner and are important formotor activ-
ity (13, 14). Bookwalter et al. (15) have demonstrated that a
heterologously expressed TgMyoA requires bothMLC1 and an
ELC in order to move actin at its fastest speed. In addition to
MyoA and its associated light chains, a number of glideosome-
associated proteins (GAPs) have been described, including
GAP45 (16–18) (and its Coccidia-specific homolog GAP70
(19)), GAP50, and a family of three proteins with multiple
membrane spans known as GAPMs (20). Another glideosome
component, GAP40, has been described in T. gondii (19) and
has a homologue in Plasmodium based on genomic (21) and
proteomic studies (22–24), but it has not been shown experi-
mentally to be part of the glideosome in this genus. In Plasmo-
dium, most studies on MyoA have been limited to the asexual
blood stage parasites in the mammalian host, although its
essential role in glidingmotility inP. berghei ookinetes has been
demonstrated in promoter swap experiments (25).
In this study, we have examined the expression and location
ofMyoA throughout themalaria parasite life cycle, including all
invasive stages, and its temporal profile during merozoite and
ookinete development. We have examined the composition of
the glideosome in asexual blood stages by immunoprecipitation
andmass spectrometry of proteins associated with GFP-tagged
MyoA, confirming the presence of GAP40 and identifying a
newmyosin light chain. This essential-type light chain binds to
the MyoA neck adjacent to, and in addition to, MTIP. Recom-
binant PfMyoA binds actin and with both light chains bound
demonstrates increased sliding velocity of actin compared with
MyoA with just MTIP bound. This is a first important step to
reconstituting the Plasmodium glideosome in vitro, which will
be an invaluable system with which to dissect the function of,
and interplay between, different components of the complex.
Results
Myosin A is a predominantlymembrane-associated protein at
the periphery of all invasive stages of the P. berghei life cycle
Expression of the myoA gene was detected by quantitative
RT-PCR throughout the parasite life cycle, particularly in schi-
zonts and sporozoites but also in non-activated gametocytes
(Fig. 1A). To examine the synthesis and location of the protein
throughout the parasite life cycle, we produced a C-terminal
GFP-tagged MyoA expressed from the endogenous genomic
locus using a strategy we described recently for Plasmodium
falciparum MyoA and Plasmodium berghei MyoB (26) (Fig.
1B). Integration of sequence coding for GFP into the endoge-
nous MyoA locus and expression of the tagged protein was
confirmed by PCR amplification from genomic DNA using
primers that only produce a product following specific integra-
tion (Fig. 1C), by Western blotting (Fig. 1D), and by fluores-
cence microscopy (Fig. 1, F–H). Tagging MyoA with GFP
resulted in no detectable phenotype; there was no effect on the
rate of asexual parasite growth, on male gametogenesis (the
number of exflagellation centers), the number of oocysts per
mosquito gut, or the efficiency of infection via sporozoite inoc-
ulation (as judged by the number of days following infected
mosquito bite that parasites were observed by microscopy in
blood smears). In a subcellular fractionation of schizonts, the
protein was largely associated with the peripheral membrane
(carbonate-soluble) andmembrane (carbonate-insoluble) frac-
tions rather than in the soluble cell lysate (Fig. 1E), consistent
with its association with the glideosome and the IMC mem-
brane compartments. Using live parasite microscopy, the pro-
tein was detected uniformly at the periphery of segmenting
schizonts and extracellular merozoites in asexual blood stages
and at a similar location in extracellular ookinetes and salivary
gland sporozoites (Fig. 1F), consistent with location at the IMC.
Interestingly, in sporozoites, there was also a clear perinuclear
localization. In early cytomere stages of liver-stage schizonts,
the signal appeared to be cytosolic, rather than membrane-as-
sociated. In late cytomere stages, 55 h after invasion by sporo-
zoites, a clear peripheral location associated with the hepatic
merozoites was observed (Fig. 1G). The presence of myoA
mRNA in ookinete stages, as well as in non-activated gameto-
cytes as a translationally repressed transcript, prompted us to
examine the temporal profile of protein expression during the
24 h of ookinete development divided into six stages (27) (Fig.
1H). MyoA-GFP was not visible in either activated or non-ac-
tivated gametocytes andwas barely detectable in the zygote and
stage I and II ookinetes. Following the establishment of mor-
phological polarity at about 10 h after fertilization (stage III),
the protein was detectable in the growing protuberance rather
than the spherical body in the intermediate retort forms, so-
called because of their shape (stages III–V). This location was
retained in later stages, with theMyoA-GFP associatedwith the
parasite periphery in fully formedmotile ookinetes. Therewas a
concentration of fluorescence detected at the apical tip of the
mature ookinete. Immunofluorescence using an antibody
against the surface marker P28 was used to visualize the
ookinete at all stages of development.
Expression ofMyoA during P. falciparum asexual blood stage
development and formation of the glideosome complex
The use of P. falciparum allows a more detailed analysis of
asexual blood stages than can be achieved with P. berghei.
MyoA-GFP was largely undetectable by live fluorescence
microscopy until38 h after merozoite invasion of an erythro-
The glideosome needs two light chains formaximummotility
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cyte but was present in later stages at the periphery of develop-
ing segmented schizonts and free merozoites (but not associ-
ated with the food vacuole/residual body), consistent with its
proposed location at the IMC (Fig. 2A). No GFP signal was
detected in ring or trophozoite stages, indicating that the pro-
tein is not synthesized at this time, and any MyoA carried
Figure 1. Expression of GFP-tagged MyoA through the P. berghei life cycle. A, transcription of myoa analyzed by quantitative RT-PCR normalized
against two control genes, hsp70 and arginine-tRNA synthetase, at different stages of the life cycle. The mean normalized myoa expression is shown as
a horizontal bar, and S.D. values are indicated by error bars. AS, asynchronous asexual blood stages; Sch, schizonts; NAG, non-activated gametocytes; AG,
activated gametocytes;Ook, ookinetes; Spor, sporozoites. B, a plasmid containing the sequence for the 3-end of theMyoA coding region fused in frame
to the gfp sequence, together with a human dhfr-selectable marker, was used to insert the gfp sequence into the endogenousmyoa gene. C, successful
integration into the P. berghei genomewas confirmed by diagnostic PCR on genomic DNA prepared fromwild-type parasites and those with integrated
plasmid sequence using primers 9 and 10, which amplify a 1.1-kb DNA fragment from the modified myoa locus following correct integration. D,
expression of the GFP-tagged MyoA was confirmed by Western blotting of lysates from parasites expressing either the unfused GFP or the MyoA-GFP
proteins; as indicated, GFP-specific antibodies reacted with either a 29- or a 120-kDa protein, respectively. E, extracts of schizonts following hypotonic
lysis in the soluble fraction (S) and further fractionation of the insoluble material by carbonate buffer into carbonate-soluble (peripheral membrane
(PM)) and insoluble (integral membrane (IM)) fractions. Schizonts from parasites expressing either GFP (top row) or MyoA-GFP (bottom row) were used.
F, expression of MyoA-GFP at the invasive and motile stages of the parasite life cycle, detected by live fluorescence microscopy. The parasite nuclei are
stained with Hoechst 33342, and the ookinete surface is stained with Cy3-conjugated anti-P28 antibody 13.1. In the merged color image, these are blue
and red, respectively, and the MyoA-GFP is green. The differential interference-contrast (DIC) bright field images are also shown. Scale bar, 5 m. G,
expression of MyoA-GFP in liver-stage parasites at the early and late cytomere stages. Green, GFP fluorescence; blue, Hoechst 33342 staining. Scale bar,
10 m. H, temporal profile of MyoA-GFP expression during the six stages of P. berghei ookinete development. MyoA-GFP was detected by live fluores-
cence microscopy associated with the protuberance that grows out of the spherical body only at stage III, eventually forming the motile ookinete. The
parasites were co-stained with Hoechst 33342 and with Cy3-conjugated anti-P28 antibody 13.1 as a marker for the zygote and ookinete surface. The
merged (MyoA-GFP (green), P28 (red), and Hoechst (blue)) and DIC bright field images are also shown. Scale bar, 5 m.
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through with the invading merozoite is degraded rapidly fol-
lowing erythrocyte invasion. Interestingly, the protein was also
not detected in early schizonts when the first formation of the
IMC can already be detected with, for example, GFP-tagged
GAP50 (28) orGAP45 (29) and seen as small ring-shaped struc-
tures at the tips of developingmerozoites.Western blot analysis
of parasite extracts at the corresponding timepoints (Fig. 2B (i))
confirmed that GAP50 is present in early schizonts (detectable
from 24 h and strongly expressed 30 h postinvasion). Although a
small amount ofMyoA-GFP can be detected 27–36 h aftermero-
zoite invasion, the strongest expression is detected from38hpost-
invasion. AWestern blot analysis of theMyoA-GFP immunopre-
cipitate obtained from these extracts (Fig. 2B (ii)) indicates that
known components of the glideosome complex, MTIP, GAP45,
andGAP50, are associatedwithMyoA from38h after erythrocyte
invasionbyamerozoite.TaggingMyoAwithGFPhadnoeffect on
the rate of asexual blood stage parasite growth.
Location ofMyoA in P. falciparum during erythrocyte invasion
The peripheral location of MyoA-GFP in mature schizonts
and free merozoites was confirmed by an indirect immunoflu-
orescence assay (Fig. 3A). Antibodies against GFP co-localized
with antibodies against MTIP, GAP45, and GAP50, consistent
with the presence of these proteins in a complex. During eryth-
rocyte invasion, the peripheral location of MyoA did not
change during the transition from initial attachment of the
merozoite to the intracellular ring stage at the completion of
invasion (Fig. 3B). However, thereafter, the signal disappeared
until resynthesis during schizogony.
Identification of GAP40 and discovery of a secondMyoA light
chain in the P. falciparum glideosome complex
A number of proteins associated with the glideosome have
been identified in both Plasmodium and Toxoplasma species,
and the presence of GAP45, GAP50, and MTIP, some of the
known components in P. falciparum asexual blood stages, has
been confirmed above. To examine what other proteins might
be associated, we examined further the protein complex immu-
noprecipitated with GFP-specific antibodies. To do this, we
first used parasites in which GAP45 was tagged internally with
GFP (29) and then those in which MyoA was tagged at its C
terminus with GFP. In the first instance, we were interested to
see whether or not GAP40, which is a highly phosphorylated
protein (23, 30–32) present in the T. gondii glideosome (19),
is present in the Plasmodium complex. To visualize phos-
phorylated proteins associated with GFP-GAP45, we metabol-
ically labeled P. falciparum schizont phosphoproteins using
[32P]phosphate (Fig. 4). As a control, 3D7 schizonts in which
GAP45 was unmodified were used (Fig. 4, lane 1 in A and B).
The glideosome was precipitated from schizont lysates using
antibodies to GFP, and 32P-labeled phosphoproteins were visu-
alized by autoradiography (Fig. 4A). In addition to GFP-GAP45
itself, there were five labeled proteins that were absent from the
control samples. The identities of some were confirmed by
immunoprecipitation from schizont lysates with GFP antibod-
ies followed byWestern blottingwith antibodies against known
glideosome components MyoA, GAP45, GAP50, and MTIP
(Fig. 4A). Themost prominent of the phosphoproteins, with an
apparent molecular mass of just under 50 kDa, was distinct
from these four proteins, so its identitywas examined further by
mass spectroscopy following fractionation of the protein pre-
cipitate by SDS-PAGE and tryptic digestion of specific bands
(Fig. 4, B and C). This analysis clearly identified the protein as
GAP40 and confirmed the presence of GAP45 and GAP50 in
the immunoprecipitate. The high-molecular weight phospho-
protein, marked with an asterisk in Fig. 4A, was not detected in
the SYPRORuby-stained immunoprecipitate. High-level phos-
phorylation of a low-abundance protein is one possible expla-
nation for this discrepancy.
Figure 2. MyoA-GFP expression and glideosome complex formation during the late stages of intracellular development of P. falciparum in the red
bloodcell.A,MyoA-GFPexpressionwasdetectedby live fluorescencemicroscopy, and thenucleiweredetectedby stainingwithDAPI. Themerged color image
withMyoA-GFP (green) and DAPI (blue) and DIC bright field images are also shown. Schizogony starts at around 30 h postinvasion, andMyoA-GFP is detected
from38 to40h inmultinucleated forms. Scale bar, 2m.B, parasites expressingMyoA-GFPwere collectedat the indicated timepointspostinvasion, and lysates
were prepared; samples of these lysates (i) and of proteins precipitated from themwith aGFP-specific antibody (ii) were fractionated by SDS-PAGE andprobed
on Western blots with antibodies to GFP, MTIP, GAP45, and GAP50. Molecular mass markers are indicated in kDa.
The glideosome needs two light chains formaximummotility
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An immunoprecipitate from parasites expressing GFP-
tagged MyoA was also analyzed by tryptic digestion, with LC-
MS/MS analysis of resultant peptides to identify associated
proteins. Again, 3D7 schizonts in whichMyoAwas unmodified
were used as a negative control. Table 1 shows the proteins
identified only in theMyoA-GFP precipitate by the presence of
two or more specific peptides. This approach confirmed the
presence of MTIP, GAP50, GAP45, and GAP40. It also identi-
fied GAPM2 and GAPM3, which are two of the three GAPM
proteins previously shown to associatewith the glideosome and
IMC (20). The absence of GAPM1 in the precipitate could be
explained by the extremely detergent-resistant property of this
protein (20). In addition to these known or expected compo-
nents of the glideosome, 13 additional proteins were identified;
whereas it is likely that some of them represent co-purified
contaminants, it cannot be excluded that some represent real
components of the complex. For example, it is unlikely that
signal peptide peptidase,MESA, and the hexose transporter are
part of the glideosome because of their known or predicted
subcellular location: the endoplasmic reticulum (33), the para-
site-infected erythrocyte surface (34), and the parasite plasma
membrane (35), respectively. On the other hand, the protein
encoded by PF3D7_1420200 is a tetratricopeptide repeat pro-
tein related to TgUNC, demonstrated to be a member of the
UCS family of myosin-specific chaperones (15). In addition, of
particular interestwas the protein encoded byPF3D7_1017500,
which is a 134-residue polypeptide with sequence homology to
members of the EF-hand superfamily (36) and reminiscent of
myosin light chains and other calmodulin-like proteins. This
protein is a candidate second light chain for MyoA, particularly
because ithasbeenproposed that there is “space” for a second light
chain located adjacent to the MTIP-binding site (37), and addi-
tional light chains have been characterized for MyoA in T. gondii
(13, 14). Because of this and data that will be shown below, we
subsequently refer to PF3D7_1017500 as PfELC.
Bioinformatic and functional analysis of PfELC, a novel
P. falciparumMyoA light chain
The ELC protein is highly conserved across the Plasmodium
genus, with identities ranging from 59% with P. berghei to 98%
with Plasmodium reichenowi (Fig. 5A); however, there is only
moderate sequence similarity with the T. gondii MyoA ELCs
that have been described recently (13, 14). The Toxoplasma
gene database, ToxoDB, has recently split the gene encoding
TgELC1 into 2 genes, TGME49_269438 and TGME49_269442
in the ME49 strain, erroneously in our opinion. Previous
releases showed a single gene, TGME49_069440, and it was
using this release that Nebl et al. (13) were able to assign pep-
tides to TGME49_069440 from immunoprecipitates of the
glideosome. Alignment of PfELC and TgELC1 (TGME49_
069440) proteins shows 20% identity. Similarly, a second puta-
tive essential light chain, TgELC2 (TGME49_305050), that can
bind to TgMyoA in place of TgELC1, shows 21% identity with
PfELC (Fig. 5B). Homology modeling using the Phyre2 struc-
Figure 3. The location of MyoA during P. falciparummerozoite invasion. A, MyoA-GFP is located at the periphery of developing intracellular (top row of
each pair of images) and free extracellularmerozoites (bottom row) and is colocalizedwith antibodies specific for IMCproteinsMTIP, GAP45, andGAP50. In the
merged color image, the MyoA-GFP signal is green and antibodies specific for the IMC proteins are red; nuclei are stained bluewith DAPI. The DIC image is also
shown. B, individual merozoites are captured at different stages of invasion from initial attachment, through early and late invasion to the intracellular ring
stage.MyoA-GFP remains peripheral, whereas RON4, initially in the apical rhoptry neck, relocates during invasion.Merged color imageswithMyoA-GFP (green),
RON4 (red), and nuclei (blue) and DIC images are also shown, together with a schematic of each cell pair. Scale bar, 2 m.
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ture prediction server (38) suggested considerable structural
similarity with calmodulin, which is consistent with PfELC
being a functional myosin light chain. The entire sequence was
modeled on the structure of the calmodulin moiety of a genet-
ically encoded calcium indicator protein (Protein Data Bank
code 3U0K) with 76% confidence (Fig. 5C).
Interactions of PfELCwith the glideosome andMyoA
Several approaches were taken to obtain further information
on the properties of PfELC. Antibodies were generated to the
recombinant protein and used to test for the presence of the
protein in immunoprecipitated protein complexes from P. fal-
ciparum schizont lysates. The immunoprecipitate with GFP-
Figure 4. Identification of GAP40 in the P. falciparum glideosome complex. A, wild-type (lane 1) or GAP45-GFP–expressing (lane 2) P. falciparum 3D7
parasites were incubated with radiolabeled phosphate, and proteins binding to a GFP-specific antibody were immunoprecipitated, resolved on an SDS-
polyacrylamide gel, and detected by autoradiography. Bands corresponding to two unidentified proteins are labeled with one or two asterisks. In parallel, the
same samples were probed with antibodies to known components of the glideosome complex: MyoA, GAP45, GAP50, andMTIP. B, the immunoprecipitation
with anti-GFP antibody resin was repeated with unlabeled schizont lysate from wild-type (lane 1) or GAP45-GFP–expressing (lane 2) P. falciparum 3D7
parasites. Immunoprecipitated proteins were fractionated by SDS-PAGE and detected with SYPRO Ruby, and the indicated bands were excised. C, proteins
identified in the three excisedbands by tryptic digestion andmass spectrometry. The number of uniquepeptides identified for eachprotein is indicated, along
with the percentage of the protein sequence that these peptides cover. IP, immunoprecipitation;WB, Western blotting.
Table 1
Identification of proteins immunoprecipitated by GFP-Trap affinity resin together with P. falciparumMyoA-GFP using mass spectrometry
All proteins were absent from a control P. falciparum immunoprecipitation, whereMyoAwas unmodified. Proteins are ranked by the percentage of sequence coverage, and
previously known components of the glideosome/IMC are in boldface type.
Accession number Protein description Molecular mass Coverage Peptides
kDa %
PF3D7_1342600 Myosin A (MyoA) 92.2 72.5 66
PF3D7_1246400 Myosin light chain 1, myosin A tail domain–interacting protein (MTIP) 23.5 31.4 7
PF3D7_0918000 Glideosome-associated protein 50 (GAP50) 44.6 29.8 9
PF3D7_1017500 Conserved Plasmodium protein, unknown function 15.7 24.6 2
PF3D7_1033200 Early transcribed membrane protein 10.2 (ETRAMP 10.2) 38.9 22.8 6
PF3D7_1222700 Glideosome-associated protein 45 (GAP45) 23.6 19.6 4
PF3D7_0822900 Conserved Plasmodium protein, unknown function 138.2 16.2 15
PF3D7_1444300 Putative 1-acyl-sn-glycerol-3-phosphate acyltransferase 33.7 12.7 2
PF3D7_0423500 Glideosome-associated protein with multiple membrane spans 2 (GAPM2) 42.6 12.4 2
PF3D7_1416100 Putative GTP-binding protein, root hair–defective 3 (RHD3) homologue 110.5 12.2 10
PF3D7_1409400 Conserved Plasmodium protein, unknown function 30.5 10.7 5
PF3D7_1032500 Putative DER1-like protein (Der1-2) 31.0 10.3 3
PF3D7_1457000 Signal peptide peptidase (SPP) 47.5 8.0 3
PF3D7_0515700 Putative glideosome-associated protein 40 (GAP40) 51.8 7.5 4
PF3D7_0500800 Mature parasite-infected erythrocyte surface antigen, protein 2 (MESA) 168.2 6.9 6
PF3D7_1406800 Glideosome-associated protein with multiple membrane spans 3 (GAPM3) 32.9 6.7 2
PF3D7_0912400 Alkaline phosphatase 52.7 5.8 2
PF3D7_0204700 Hexose transporter (HT) 56.4 5.4 2
PF3D7_0824400 Nucleoside transporter 2 (NT2) 67.6 3.8 2
PF3D7_1420200 Tetratricopeptide repeat family protein, putative 147.9 1.9 2
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specific antibodies from cells expressing either MyoA-GFP or
MyoB-GFP was probed with antibodies raised against recom-
binant PfELC. This analysis revealed a 14-kDa protein associ-
ated withMyoA in the glideosome complex, with very little free
unbound protein, and none was detected associated with the
MyoB complex (Fig. 5D). When the immunoprecipitation was
performed with anti-MTIP antibodies and a lysate of schizonts
or merozoites from 3D7 parasites, Western blotting with the
PfELC-specific antibodies detected a 14-kDa protein in the
complex, not only confirming the presence of PfELC but also
demonstrating that it is present with MTIP in the same com-
plex (Fig. 5E).
Figure 5. The putative ELC binds to MyoA but not MyoB and is in the P. falciparum glideosome complex together with MTIP. Shown is alignment of
Plasmodium ELC homologues (A) and PfELC (B) with the two T. gondiiMyoA ELCs. Identical residues are shaded black, and biochemically similar residues are shaded
gray. Percentage identities to PfELC are displayed. Gene identifiers are as follows. PfELC, PF3D7_1017500; PrELC, P. reichenowi PRCDC_1016900; PvELC, Plasmodium
vivaxPVX_001745;PcyELC,PlasmodiumcynomolgiPCYB_061180;PkELC,PlasmodiumknowlesiPKNH_0601700;PcELC,PlasmodiumchabaudiPCHAS_0501900;PyELC,
PlasmodiumyoeliiPY02639;PbELC,P. bergheiPBANKA_0501800;TgELC1,T. gondiiTGME49_069440;TgELC2,T. gondiiTGME49_305050.C, structural homologymodel
of ELCgeneratedusingPhyre2.D, proteins inextracts fromwild-type (3D7) schizonts and thoseexpressingeitherMyoA-GFPorMyoB-GFPwere immunoprecipitated
with resin-bound antibodies to GFP and then probed byWestern blottingwith antibodies to GFP and ELC. I, input lysate;U, unbound protein; E, protein eluted from
the resin.E, theprotein complex containingMTIPalso containsELC. Theglideosomecomplex from lysatesof schizonts (S) andmerozoites (M) of 3D7wasprecipitated
with anti-MTIP antibodies and resolvedby SDS-PAGE, and thepresence of ELCwas determinedbyWesternblottingwith specific antibodies. A preimmuneantibody
samplewas used to immunoprecipitate from the lysates as a control. IP, immunoprecipitation;WB, Western blotting.
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PfELC was expressed in recombinant form as a His-tagged
fusion protein (Fig. 6A). Far UV-CD spectra indicated that
PfELC is mainly helical, with 32%  helix, 17%  sheet, and 20%
turn (Fig. 6, B (i)). The addition of 1 mM calcium ions had no
effect on either the near- or far-UV spectrum, suggesting that
calcium does not bind to the protein or that there is no change
in secondary or tertiary structure of the protein upon binding.
This is supported by the fact that there are no appropriately
placed acidic residues that would normally be involved in the
coordination of calcium ions in calmodulin-related proteins
with canonical EF-hands (39). To examine whether or not
PfELC interacts directly with MyoA, the binding of the recom-
binant protein to peptides derived from the neck region of
MyoA was examined. Amino acid residues 760–818 of MyoA
constitute its neck region, and MTIP has previously been
shown to interact stronglywith peptides from theC terminus of
the neck (40, 41). Using biolayer interferometry, we measured
the affinity of PfELC to overlapping biotinylated peptides cor-
responding to residues 770–787, 786–803, and 801–818 of
MyoA. There was no observable binding to peptide 770–787,
but both peptides 786–803 and 801–818 bound to PfELC, with
calculated Kd values of 0.48 0.15 and 0.32 0.07 M, respec-
tively (Fig. 6C). There was no effect of 1 mM calcium on the
affinity to any of the three peptides. AsMTIPhas been shown to
bind to the more distal MLC-binding site, but not to a peptide
representing residues 781–801 of PfMyoA (41), we propose
that PfELC binds to a region within 786–803, whereas MTIP
binds to a region within 801–818 (Fig. 6D).
The subcellular location of PfELC
A parasite line expressing an HA-tagged PfELC was gener-
ated by single homologous recombination into the endogenous
gene locus (Fig. 7A), and integration into the PfELC locus was
confirmed by PCR in two independent clones (Fig. 7B). The
17-kDa tagged protein could be detected byWestern blot anal-
ysis of parasite extracts, and the time of synthesis corresponded
to that of MTIP and GAP45 in mature schizonts, peaking at
44–46 h postinvasion (Fig. 7C). By 48 h after invasion, many of
the schizonts had ruptured, and the merozoites had gone on to
invade fresh erythrocytes, explaining the apparent drop in
expression of all glideosome components at this time point.
Immunofluorescence analysis of fixed blood-stage P. falcipa-
rumwith HA-specific antibodies showed co-localization of the
protein with GAP45 and MTIP in late, segmented schizonts
(Fig. 7B).
Recombinant PfMyoA binds to actin
As a first step to reconstitute the functional complex in vitro,
we expressed PfMyoA using an in vitro transcription/transla-
tion system and examined its ability to bind to actin. Soluble
GST-tagged PfMyoA was purified (Fig. 8A), and its ability to
bind actin was examined using an optical tweezer-based single-
molecule system (Fig. 8, B and C). A total of 244 acto-MyoA–
binding events were recorded in 2 M ATP, a concentration
chosen based on the affinity of TgMyoA for mant-ADP (10).
The MyoA “working stroke” was 3 nm, as measured from the
shift in mean position of the observed event distribution (Fig.
Figure 6. The putative MyoA ELC binds to the neck region of MyoA. A, purification of recombinant His-PfELC protein. B, far-UV (i) and near-UV (ii) circular
dichroism spectra of recombinant protein indicate that it is highly structured, with 32% -helix, 17% -sheet, 20% turn. C, PfELC binding to immobilized
peptides corresponding to residues 770–787, 786–803, and 801–818 of MyoA was measured by biolayer interferometry, using increasing concentrations of
PfELC. The dissociation constant (Kd) with S.E. was calculated from each of the curves. D, the amino acid sequence of the neck region of MyoA, showing the
location of the peptides used for analysis, the MTIP-binding site, and the proposed ELC-binding site.
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Figure 8. Recombinant MyoA binds actin. A, Coomassie-stained SDS-PAGE showing affinity-purified GST-MyoA, marked with an asterisk. B, an acto-
myosin event as determined using optical tweezers, with an actin filament held between two beads, a left-hand bead (blue) and a right-hand bead (red),
with the MyoA molecule on a third bead. Because of the high sensitivity required in these single-molecule measurements, Brownian motion causes a
significant amount of displacement noise, and when MyoA binds to actin, that event is evident by a sudden decrease in the S.D. of the displacement
noise (shown in black). Events are scored by thresholding data falling below a fixed value (dotted red/blue line). Note that movement of the left-hand
bead and its S.D. are offset by200 and30 nm, respectively, for clarity. C, improved visualization of binding events is achieved by moving the beads
back and forth using a 10-Hz triangular wave function of 100-nm amplitude.D, displacement histogram generated from 244 acto-MyoA–binding events
with a fitted Gaussian distribution. The magnitude of the displacement (nm) is displayed on the x axis, and the number of observations at that value
(Nobs) is displayed on the y axis. The average movement caused by the myosin power stroke was measured as 3 nm. E, acto-MyoA event lifetime
distributions measured at two MgATP concentrations, 8 M (blue symbols) and 0.3 M (red symbols), confirm that the event lifetimes are strongly
dependent on [MgATP]. The x axis shows the duration of the binding event (in seconds); the y axis is the number of observations (Nobs) at that value. The
lines are single-exponential least-square fits with rate constants 53 s1 (blue) and 6.9 s1 (red).
Figure 7. PfELC expression matches that of known glideosome components in P. falciparum schizonts. A, scheme for modifying the PF3D7_1017500
gene locus by single-crossover homologous recombination to C-terminally modify the ELC protein with a triple-HA tag. B, PCR screening of parental 3D7
parasites and two independently generated clones. PCR product from the wild-type locus was amplified using primers 13 and 14 (WT), whereas a product (I)
from the modified locus was amplified using primers 13 and 15. C, Western blot analysis of HA-tagged ELC, MTIP, and GAP45 proteins present during a time
course of schizont development. D, immunofluorescent detection of HA-tagged ELC and either MTIP or GAP45 in mature schizonts and merozoites. Merged
color images are also shown, with ELC-HA (green) and MTIP or GAP45 (red). Nuclei are stained with DAPI (blue). Scale bar, 2 m.
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8D). Specificity of the acto-MyoA interaction was established
using two different ATP concentrations of 0.3 and 8 M and
measuring the duration of acto-MyoA–binding events fitted to
a single-exponential decay. The data were consistent with a
single rate-limiting step, due to ATP binding to the acto-MyoA
rigor complex. At 0.3 and 8 M ATP, we observed interactions
lasting on average 0.1 s (Nobs  79) and 0.013 s (Nobs  165),
respectively, and consistent with MgATP binding and dissoci-
ating the acto-MyoA rigor complex with second-order kinetics
of15 106 M1s1 (Fig. 8E).
MTIP and PfELC are required formaximumPfMyoA-dependent
motility in vitro
To examine the effects of light chain composition on MyoA
motility, we expressed and purified recombinant MyoA
together with MTIP and MTIP/PfELC. For these studies, we
required more material than it was possible to generate using
the in vitro transcription/translation system that we used in the
single-molecule PfMyoA studies described under “Recombi-
nant PfMyoA binds to actin.” We opted for a heterologous
expression system that would allow co-expression of PfMyoA
and its light chains. Bookwalter et al. (15) showed recently that
TgMyoA can be expressed well in insect cells but requires
Unc45 to fold correctly. Therefore, we followed the same strat-
egy and co-expressed the P. falciparumUnc45 homologue and
PfHsp90 together with PfMyoA, and we were able to purify
functional MyoA in complex with MTIP or with both MTIP
and PfELC. Fig. 9A shows size-exclusion chromatography
traces of the two purifications, indicating a pure, homogeneous
complex. Fig. 9B shows the complexes separated by SDS-
PAGE, indicating that the complexes contain the full comple-
ment of light chains included in the co-expression system. A
peculiarity is that MTIP migrates as two bands on the SDS-
PAGE. We have performed mass spectrometry on each of the
Figure9.MTIP/ELC-decoratedMyoAshows increased invitro slidingmotility.A, sizeexclusionchromatographyof co-expressedMyoAandMTIP (solid line)
andMyoA,MTIP, and ELC (dotted line).B, Coomassie-stained SDS-PAGEof thepurifiedMyoA-light chain complexes.C,motility of nitrocellulose-capturedMyoA
complexes;D, the corresponding capture ofMyoA complexes via an anti-His tag antibodymeasuring the velocity of actin filamentmovement in the presence
ofATP.A solid line represents aGaussian fit to each correspondinghistogram. E, the actin-activatedATPaseofMyoA-MTIP andMyoA-MTIP-PfELCwasestimated
using an NADH-coupled assay to quantify the rate of ATP hydrolysis.
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two bands to confirm they are bothMTIP.We are unsure what
is the cause of this aberrant migration.We studiedMyoA com-
plexes using an in vitromotility assay. MyoAwas captured on a
coverslip by coating the surface either with nitrocellulose (Fig.
9C) or with an anti-His tag antibody (Fig. 9D), which orients the
head domain away from the surface. Without the addition of
ATP, actin filaments bound to the surface andwere non-motile.
FollowingATP addition, the filaments startedmoving, showing
ATP-drivenmotility (supplementalMovie 1).We also observed
significant actin filament fragmentation even at the lowest sur-
face densities used that would still support smooth filament
slidingmotility (50g/mlmyosin protein added to the flow-cell
surface). In our assay,95% of actin filaments showed smooth
gliding movement with only a small number of non-moving
filaments. This observation is firm evidence that our MyoA
preparation contained very few so-called “dead-heads” (myosin
dead-heads bind actin in an irreversible, tightly bound state).
Nitrocellulose- and antibody-captured MyoA-MTIP gliding
velocitieswere 0.13 0.04ms1 (Nobs 414) and 0.25 0.06
m s1 (Nobs  761), respectively, showing that antibody
immobilization increased the gliding velocity2-fold. Further-
more, the MyoA-PfELC-MTIP complex moved filaments
2-fold faster than the MyoA-MTIP complex and produced
actin gliding velocities of 0.27  0.06 m s1 (Nobs  404) on
nitrocellulose and 0.46  0.07 m s1 (Nobs  329) when
immobilized via anti-His antibody. The maximum actin-acti-
vated ATPase activity (Vmax) and actin affinity (Km) were 12.9
s1 and 42 M for MyoA-MTIP and 11.2 s1 and 37 M for
MyoA-MTIP-PfELC, respectively (Fig. 9E).
Discussion
We have taken advantage of the ability to GFP-tag MyoA to
study in detail its time of synthesis and location in the life cycle
of themalaria parasite, using fluorescencemicroscopy with live
parasites expressing the tagged gene from the endogenous
genomic locus. No growth phenotype was associated with the
tagging ofMyoAwithGFP. The protein ismost abundant in the
invasive and motile stages. MyoA is an integral component of
the glideosome complex, which is associated with the IMC
located below the parasite plasmamembrane. In the P. falcipa-
rum asexual blood stage, there is no IMC in the ring and tro-
phozoite stages, and genesis of the IMC commences soon after
the onset of nuclear division, as part of the establishment of
polarity for each developingmerozoite, and is detected as intra-
cellular ring-shaped structures associated with the individual
nuclei (28, 29). At this stage, MyoA-GFP cannot be detected in
the cell. However, as the IMC continues to grow, leading even-
tually to cell segmentation and individualmerozoite formation,
MyoA accumulates on the IMC, which can be distinguished
from the parasite plasma membrane in mature schizonts
because it does not surround the food vacuole. In released
extracellular merozoites, MyoA-GFP has the characteristic
peripheral location but then rapidly disappears following eryth-
rocyte invasion. Themechanism bywhich the disappearance of
the glideosome occurs is undetermined. It is likely that protea-
some-mediated degradation of the protein components occurs,
although the signaling mechanisms that underlie this are
unknown. Throughout the P. berghei life cycle, MyoA is most
abundant in the extracellular motile and invasive forms (mero-
zoites, ookinetes, and sporozoites). In the sexual stages,
althoughmyoamRNA is detected in gametocytes, the protein is
barely detectable in gametocytes or the zygote, and protein is
only evident once ookinete differentiation is under way. Trans-
lational repression is a mechanism of post-transcriptional gene
regulation in Plasmodium, and myoa has previously been
shown to be regulated in this way (42, 43), with protein synthe-
sis occurring after fertilization. Following formation of the pro-
tuberance that heralds development of the polarized ookinete,
MyoA-GFP begins to be deposited at the periphery of the grow-
ing protuberance through the retort forms until finally the
entirematuremotile ookinete is labeledwithGFP fluorescence.
The deposition of MyoA in this way provides insight into the
formation of the IMC in the developing ookinete. It is possible
thatMyoA activity is important in providing the force required
for the developing protuberance to extend away from the
spherical body and acquire the characteristic shape of the
ookinete. Similarly, the periphery of the salivary gland sporozo-
ite is uniformly labeled with MyoA-GFP. Interestingly, the
sporozoite was the only parasite stage in which we observed an
additional perinuclear MyoA-GFP localization. It may be that
the IMC plays a role inmaintaining the shape of the sporozoite.
A gene knock-out in P. berghei of PbIMC1a, which encodes a
sporozoite-specific protein with homology to articulins and
localizes to the sporozoite IMC, resulted in salivary gland
sporozoites with an abnormal morphology. The sporozoites
had a characteristic bulge at the position of the nucleus, and the
nucleus appearedmore rounded than the usual slender nucleus
of sporozoites (44). It is possible thatMyoAplays a role inmain-
taining the cellular architecture and shape of the sporozoite in
addition to its role in cell motility. The early cytomere stage of
liver-stage parasites exhibits cytosolic MyoA-GFP fluores-
cence, with peripheral localization only detected in the late,
segmented cytomere stage. It may be that in the early cytomere
stage there is a pool of MyoA that is present before localization
to the IMC in the late cytomere stage.
The GFP tag has also proven very useful to purify MyoA and
associated proteins in P. falciparum. This approach confirmed
the presence of MTIP, GAP45, and GAP50, identified previ-
ously by Western blotting (26), and GAPM2 and 3, previously
identified as components of the apicomplexan glideosome (20).
A thirdmember of this family (GAPM1) was not detected here,
probably because of its poor solubility in the detergent used.
We also identified GAP40 as a component of the glideosome
and confirmed that it is one of the major phosphorylated pro-
teins in the complex. Although GAP40 has been described as a
component of the T. gondii glideosome, it has not previously
been shown to be a component of this structure inPlasmodium.
The fact that we only detected two peptides attributable to
GAP40 (3.3% sequence coverage) in our immunoprecipitation/
mass spectrometry studies is probably due to the hydrophobic
nature of this protein. GAP40 has 10 predicted membrane-
spanning regions, with very small loops between them. The two
peptides we detected map to the short loop between predicted
transmembrane domains 2 and 3. Hydrophobic peptides, such
as those that would make up the majority of a GAP40 tryptic
digest, are often very poorly ionized in the mass spectrometry
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workflow, making detection very difficult. This could also
explain whyGAP40 has, until now, not been detected as a com-
ponent of the Plasmodium glideosome.
In addition to these known or expected components of the
Plasmodium glideosome, several additional proteins were also
identified. Whereas some, such as the signal peptide peptidase
or MESA, are likely to be simple contaminants due to their
known subcellular location, this cannot be said for some of the
other proteins. Their presence or absence in complex with
MyoA or other components of the glideosome complex needs
to be examined in reciprocal immunoprecipitation experi-
ments using, for example, a variety ofGFP-tagged proteins. The
tetratricopeptide repeat-containing protein encoded by gene
PF3D7_1420200 is similar in sequence to TgUNC in T. gondii
(TGME49_249480), a member of the UCS family of myosin
chaperones (15). Its presence in our immunoprecipitations
supports a conservedmechanism ofmyosin folding in a diverse
range of organisms (45). Another of the proteins identified by
mass spectrometry, coded by the gene PF3D7_1017500 and
annotated as a conserved protein of unknown function, has a
sequence suggesting that it might be a myosin light chain. It
shows relativelyweak homologywithT. gondiiELCs, indicating
that in this case, it would not have been possible to identify the
Plasmodium ELC by this criterion alone. Interestingly, the
abundance of this protein, like that of other glideosome
components, including MyoA and MTIP, was significantly
decreased in parasites blocked during schizont development
(46). Unlike the situation in T. gondii tachyzoites, where two
ELCs have been identified that bind to TgMyoA in a mutually
exclusive manner (14), we found no evidence of light chains
other than MTIP and ELC in our immunoprecipitations. This
may indicate different modes of regulation and control of the
glideosome in these species. Interestingly, there is redundancy
in the ELCs of TgMyoA. Either of the genes encoding TgELC1
or -2 can be deletedwith no effect onparasite viability; however,
deletion of both genes causes a marked reduction in the para-
site’s ability to invade host cells (14). We have been unable to
disrupt the elc gene in either P. berghei or P. falciparum, sug-
gesting that the ELC is essential for parasite viability and that
this redundancy does not exist in Plasmodium species. This is
supported by the inability to disrupt Pbelc in the PlasmoGEM
project (http://plasmodb.org/plasmo/,9 RMgm-1936) (47,
72). Utilizing approaches that are now available in P. falcipa-
rum, such as the expression of a Cre recombinase that
dimerizes in response to the presence of a small molecule to
rapidly and inducibly delete genes (48), will be essential to fur-
ther analyze the specific deficits that occur in parasite growth
and development in the absence of PfELC.
We tested the binding of PfELC to several peptides derived
from the neck region of MyoA, which encompass the MTIP-
binding site at the C terminus of the molecule and the adjacent
putative light chain–binding site previously identified by ho-
mologymodeling (37). PfELC bound to both the knownMTIP-
binding site and the adjacent proximal site. It has been shown
previously that MTIP cannot bind to a peptide composed of
residues 781–801 of the MyoA neck (41). This covers all of the
sequence of peptide 786–801 used in these studies, which we
have shown binds strongly to PfELC. These data, along with
the co-precipitation of PfELC with MTIP andMyoA from par-
asite lysates, confirm that MyoA is decorated with two light
chains and that PfELC binds to sequences of MyoA adjacent to
theMTIP-binding site. A 30-amino acid region of the T. gondii
MyoA neck (residues 770–799) has been demonstrated to be
the binding site for TgELC1 and -2 (14). The region of PfMyoA
that we have demonstrated binds to PfELC is at the C terminus
of the equivalent region of PfMyoA, suggesting a similar
arrangement of the two light chains on both TgMyoA and
PfMyoA. We found no evidence of an effect of Ca2	 on the
binding of PfELC toMyoA neck peptides or on the structure of
PfELC itself, as judged by biolayer interferometry and circular
dichroism, respectively. Studies inT. gondii have demonstrated
Ca2	 binding by ELC1, and, by sequence homology, it is
assumed that TgELC2 will also bind Ca2	. Specific amino acid
residues have been suggested (Asp15, Asp17, andAsp19) or dem-
onstrated (Asp15) to be required for Ca2	 coordination in
TgELC1 (14). In the equivalent region of PfELC, these residues
are Ser17, Cys19, and Asp21, respectively. The sequence differ-
ences here support our observations that Ca2	 has no effect on
the overall structure of PfELC or on its binding to PfMyoAneck
peptides, in that the acidic residues required to coordinate
Ca2	 in canonical EF-handmotifs (39) are absent. This suggests
that there may be subtle differences in the regulation of ELC
binding in the Plasmodium versus Toxoplasma glideosome.
Additionally, we expressed and purified recombinant MyoA
that bound to actin and recombinant MyoA decorated with
MTIP or MTIP/ELC that we used to measure sliding velocities
by in vitro motility assays. The motility was induced by the
addition of ATP, and only a small proportion of actin filaments
were static, suggesting only a small fraction of non-functional
or incorrectly folded myosin heads after a two-step purifica-
tion. Importantly, MyoA with both MTIP and ELC bound had
about a 2 times higher velocity in comparison with MyoA with
MTIP alone. This suggests that ELC plays a significant role in
Plasmodiummotility. Our results are in line with results using
TgMyoA,whichmoves actinwith approximately 2 times higher
velocity when decorated by two light chains (15). It would be
interesting to know whether the step size of the MyoA-MTIP-
ELC complex is increased compared with that of the MyoA-
MTIP complex, as this could be a possible explanation for the
increased velocity that we observe in our motility studies for
MyoA with its full complement of light chains. Because the
actin-activated ATPase activity of MyoA-MTIP and MyoA-
MTIP-PfELC was virtually identical, our conclusion is that the
increased in vitro motility sliding velocity seen with MyoA-
MTIP-PfELC compared with MyoA-MTIP alone cannot be
explained by a change in catalytic turnover rate (ATPase activ-
ity). It is most easily explained by the MTIP/ELC light chain
combination having a longer effective lever arm and working-
stroke distance, meaning that actin is moved approximately
twice as far for each molecule of ATP hydrolyzed.
The glideosome is a molecular motor that has a key role
throughout the parasite life cycle. The key components of the
glideosome for moving actin filaments are MyoA and its two
9 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party hosted site.
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associated light chains, and we have now established a system
where the interplay and function of these three glideosome
components can be studied. This will also allow the develop-
ment and assessment of inhibitors that target the glideosome
function and block invasion of host cells.
Experimental procedures
Ethics statement for animal work
Animal work at the University of Nottingham was approved
by the local animal welfare and ethical review body and by the
United Kingdom Home Office under project license numbers
40/3344 and 30/3248 in accordance with the United Kingdom
Animals (Scientific Procedures) Act 1986 and in compliance
with European Directive 86/609/EEC for the protection of ani-
mals used for experimental purposes. 6–8-week-old female
Tuck-Ordinary (TO) outbred mice (Harlan) were used for
these experiments.
At the University of Bern, experiments were conducted in
strict accordance with the guidelines of the Swiss Tier-
schutzgesetz (animal rights laws) and approved by local author-
ities. The BALB/c mice used in these experiments were
between 6 and 10 weeks of age and bred in the central animal
facility of the University of Bern.
Analysis of PbMyoA gene expression by quantitative RT-PCR
Blood stage P. berghei parasites from infected mice (day 4
postinfection)were cultured in vitro (49), and the following day,
schizont-infected cells were purified on a 60% (v/v) Nycodenz/
PBS gradient. Gametocytes were purified on a 48% (v/v) Nyco-
denz gradient and washed twice in RPMI 1640 medium, and
gamete formation was activated by transfer to ookinete
medium (RPMI 1640 containing 25 mM HEPES, 25% fetal
bovine serum, 10 mM sodium bicarbonate, 50 mM xanthurenic
acid at pH 7.6) for 30 min at 20 °C. For ookinete preparation,
parasites frommice day 5 postinfectionwere placed in ookinete
medium for 24 h at 20 °C, other parasite stages were lysed in red
blood cell lysis buffer for 30min, and then ookinetes were puri-
fied on a 63% (v/v) Nycodenz gradient in PBS. On day 14 post-
feeding, mosquito guts were dissected and crushed in a loosely
fitting homogenizer to release sporozoites, which were then
quantified using a hemocytometer (50).
Total RNA isolation, cDNA synthesis, and PCR analysis were
as described previously (49). Expression was determined using
the Pfaffl method (51), using hsp70 (PBANKA_0818900) and
arginyl-tRNA synthetase (PBANKA_1434200) as reference
genes. All primer sequences are available on request.
Parasite genetic modification
GFP tagging of P. berghei genes—P. berghei myoa (PBANKA_
1355700)wasmodified by single homologous recombination to
insert a sequence coding for a C-terminal GFP tag (Fig. 1B),
using the p277 vector that contains a human dhfr selection cas-
sette (52). An 833-bp region of Pbmyoa starting 1.86 kb down-
streamof theATG start codon and omitting the stop codonwas
amplified using primers 7 and 8 and inserted into the vector
using KpnI andApaI restriction sites. The construct was linear-
ized by digestion with PacI and used to transfect the P. berghei
ANKA 2.34 line by electroporation (53). The electroporated
parasites were injected into naive mice, and transgenic para-
sites were selected with pyrimethamine (49) and analyzed by
diagnostic PCRusing the primers 9 and 10 to determine correct
integration of the gfp sequence at the targeted locus (Fig. 1C).
Western blottingwithGFP-specific antibodieswas used to con-
firm expression of full-length tagged protein of the predicted
size (Fig. 1D).
Tagging of P. falciparum genes—P. falciparum (3D7) was cul-
tured in RPMI 1640 medium containing Albumax II according
to previously described methods (54). GFP tagging of P. falcip-
arumMyoB, MyoA, and GAP45 has been described previously
(26, 29). ForHA-tagging of P. falciparumELC at its C terminus,
a 632-bp DNA fragment of the gene was amplified using prim-
ers 11 and 12 and cloned via XmaI and AvrII sites into the
pHH4-HA vector,10 a derivative of pHH1 (55). 100 g of DNA
was used to transfect ring-stage P. falciparum as described pre-
viously (56). Transgenic lines were selected with 10 nM
WR99210 (a gift from Jacobus Pharmaceuticals). Plasmid inte-
gration wasmonitored by diagnostic PCR screening with prim-
ers 13 and 14 to detect the unmodified locus and primer pair 13
and 15 to detect integration (Fig. 7B).
Antibodies
Polyclonal rat anti-PfMyoA antibodies were raised to a pep-
tide of the sequence MVNKINELNNYFRINSTFINKSENE by
Pepceuticals Ltd. according to their standard protocol. Mouse
anti-PfELC antibodies were raised by immunization of female
BALB/c mice with recombinant His-tagged protein (produc-
tion of which is described below). Other primary polyclonal
antibodies and mAbs used were anti-PfMTIP (40), anti-Pf-
GAP45 (18), anti-PfGAP50 (26), anti-PfRON4 mAb (57), and
anti-PbP28 mAb 13.1 (58), which are described in the refer-
enced works. Rabbit anti-GFP11 and rat anti-HA (monoclonal
3F10; Roche Applied Science) antibodies were used to detect
tagged proteins. Species-specific Alexa Fluor 488– and 594–
conjugated secondary antibodies were obtained from Molecu-
lar Probes.
Microscopy
Live imaging of GFP-tagged parasite lines—P. berghei asexual
blood stage infections in mice were initiated by intraperitoneal
injection of parasite-infected blood. The asexual, gametocyte,
and ookinete stages were observed using Hoechst 33342 dye
(Molecular Probes) in ookinete medium and Cy3-conjugated
mouse mAb 13.1 to recognize the p28 protein on the surface of
activated female gametes, zygotes, and ookinetes. To examine
mid-gut infection, guts were dissected 14 days after mosquito
feeding on infected blood and mounted under Vaseline-
rimmed coverslips after stainingwithHoechst 33342 for 10–15
min. On day 21 post-feeding, guts and salivary glands were dis-
sected and crushed separately in a loosely fitting homogenizer
to release sporozoites, which were then quantified using a
hemocytometer and used for imaging. Microscopy was per-
formed using a Zeiss AxioImager M2 microscope (Carl Zeiss,
10 E. Knuepfer, unpublished data.
11 E. Knuepfer and A. A. Holder, unpublished data.
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Inc.) fitted with an AxioCam MRm digital camera. P. berghei
liver stage parasites were prepared and imaged as described
previously (26), with the exception that infections were per-
formed in HeLa cells.
P. falciparum-infected red blood cells were prepared for live
imaging as described previously (26, 29) and viewed using an
Axio Imager M1 microscope (Carl Zeiss).
Indirect immunofluorescence assay—Thin smears of para-
sites were fixed with 4% paraformaldehyde for 30 min at room
temperature. The fixed cells were permeabilized with PBS con-
taining 0.1% Triton X-100 for 5 min followed by blocking in 3%
BSA (w/v) in PBS at 4 °C overnight. Primary antibodies were
diluted as required; species-specific Alexa Fluor 488– and
594–conjugated secondary antibodies (Life Technologies)
were used to visualize primary antibody binding. All antibody
dilutions were carried out with 3% BSA (w/v) in PBS. Slides
were mounted for microscopic examination using Prolong
Gold anti-fade reagent with DAPI (Life Technologies). Slides
were viewed using a Zeiss Axioplan 2 microscope, and images
were captured using a Zeiss Axiocam MRc digital camera and
Axiovision version 4.8.2 software and prepared for publication
using Adobe Photoshop.
To image stages of invasion of erythrocytes, tightly synchro-
nized PfMyoA-GFP–expressing late-stage schizonts were
mixed with erythrocytes and samples taken after 2, 5, 8, 10, and
30 min and fixed in solution with 4% paraformaldehyde with
0.01% glutaraldehyde for 60 min at room temperature. Further
processing was carried out as described previously (59).
Preparation of parasite lysates, immunoprecipitation of GFP
fusion proteins, and analysis of the precipitates byWestern
blotting and LC-MS/MS
Parasite lysates—Schizonts from MyoA-GFP, GAP45-GFP,
and 3D7 P. falciparum parasite lines were first lysed in 0.15%
(w/v) saponin in PBS and harvested by centrifugation, and then
proteins were extracted using 10 cell pellet volumes of ice-cold
lysis buffer (0.5%Nonidet P-40, 150mMNaCl, 10mMTris-HCl,
pH 7.5, 1 Complete protease inhibitors (Roche Applied Sci-
ence)). Samples were cleared by centrifugation at 100,000  g
for 10 min. The detergent concentration in the samples was
reduced to 0.2% by dilution with 150mMNaCl, 10 mMTris, pH
7.5, 1 Complete protease inhibitors.
For P. berghei, subcellular fractionation was performed as
described previously (60). Briefly, cell pellets of MyoA-GFP or
WT-GFP schizonts were resuspended in hypotonic lysis buffer
(10 mMTris-HCl, pH 8.4, containing 5 mM EDTA and protease
inhibitors), freeze/thawed twice, and then incubated for 1 h at
4 °C. Following centrifugation at 100,000 g for 30min, super-
natant was collected as the soluble protein fraction. The
remaining pellet was resuspended in carbonate solution (0.1 M
Na2CO3, pH 11.0, containing protease inhibitors), incubated
for 30 min at 4 °C, and then centrifuged at 100,000  g for 30
min. The resulting supernatant was classified as the peripheral
membrane fraction, and the pellet was washed and solubilized
in 4% SDS and 0.5% Triton X-100 in PBS and classified as the
integral membrane fraction. Equal amounts of these three frac-
tions were analyzed by Western blotting using anti-GFP
antibody.
Radiolabeling P. falciparumphosphoproteins—P. falciparum
schizonts (39 h postinvasion) were enriched by centrifugation
through 70% Percoll (GE Healthcare). The purified schizonts
were washed twice with phosphate-free RPMI 1640 medium
containing 10% human serum and incubated at 37 °C for 30
min. Then 25 MBq of [32P]phosphate (PerkinElmer Life Sci-
ences) was added to the culture, and the incubation was con-
tinued for 2 h. The schizonts were then washed twice with
serum-free RPMI 1640 medium. The [32P]phosphate-labeled
schizonts were used for immunoprecipitation using the GFP-
Trap system (Chromotek) as described below.
Immunoprecipitation—Parasite lysates were precleared by
incubation with blocked agarose beads for 1 h, and then the
supernatant was incubated with GFP-Trap agarose beads for
2 h at 4 °C with end-over-end rotation. The beads were washed
extensively with 150 mM NaCl, 10 mM Tris, pH 7.5, and then
subjected to a furtherwash in 300mMNaCl, 10mMTris, pH7.5.
Finally, the beads were resuspended in 5 volumes of 2 SDS-
PAGE sample buffer and boiled for 5 min before fractionation
of the proteins by SDS-PAGE.
Western blotting—Cell lysates were separated under reduc-
ing conditions on NuPAGE gels (Life Technologies). Proteins
were transferred to nitrocellulose and blocked in 5% (w/v) non-
fat milk in PBS containing 0.2% Tween 20. Primary antibodies
were diluted in 5% (w/v) nonfat milk in PBS containing 0.2%
Tween 20. Species-specific horseradish peroxidase-conjugated
secondary antibodies (Bio-Rad) were used, and the signal was
developed using enhanced chemiluminescence (GE Health-
care). Blots were exposed to Biomax MR film (Eastman Kodak
Co.), and images were prepared for publication using Adobe
Photoshop.
Protein identification by LC-MS/MS—Proteins immunopre-
cipitated from GFP-GAP45 parasite lysates were run on a 10%
NuPAGE BisTris gel (Life Technologies) and stained with
SYPRO Ruby (Thermo Scientific). The protein bands were
visualized using a Pharos FXPlusmolecular imager and excised
using an EXQuest spot cutter (both from Bio-Rad). Proteins
immunoprecipitated from MyoA-GFP or 3D7 parasite lysates
were run 4 mm into a 10% NuPAGE BisTris gel (Life Technol-
ogies) and then excised using a clean scalpel blade. In both
cases, proteinswere reduced for 1 h in a solution of 20mMDTT,
200 mM ammonium bicarbonate, 50% acetonitrile (ACN) and
alkylated for 20 min in a solution of 5 mM iodoacetamide, 200
mM ammonium bicarbonate, 50% ACN, before overnight
trypsin digestion. The resulting digests were analyzed by LC-
MS/MS using an Ultimate 3000 nanoRSLC HPLC, equipped
with a 50 cm 75-mAcclaim Pepmap C18 column, coupled
to an LTQ Orbitrap Velos Pro equipped with a Nanoflex elec-
trospray source (all from Thermo Scientific). A gradient of
6–32% ACN/0.1% formic acid over 48 min was used at a flow
rate of 0.3 l/min. The Orbitrap was operated in data-depen-
dent acquisition mode with a survey scan at 60,000 resolution
and up to the 10 most intense ions selected for MS/MS. Raw
files were processed using Proteome Discoverer version 1.3
(Thermo Scientific) with Mascot version 2.4 (Matrix Science)
as the search engine against the appropriate protein database. A
decoy database of reversed sequences was used to filter the
results at a false detection rate of 1%.
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Bioinformatic analyses
Alignment of ELC sequences was performed using CLC
Sequence Viewer version 6 (Qiagen), and graphics were pre-
pared using BoxShade. A structural model of PfELC was con-
structed using the Phyre 2 protein fold recognition server (38).
Images were prepared using CCP4molecular graphics software
(61).
Cloning and expression of recombinant PfELC
RNA was prepared from late P. falciparum parasites (36 h
postinvasion) using TRIzol (Life Technologies) and cDNA
made from this using the reverse transcription system with oli-
go(dT) primers (Promega). Primers 16 and 17 were used to
amplify elc from cDNA, and the product was cloned into the
pET46-Ek-LICexpressionvector(Novagen)usingligation-inde-
pendent cloning. After verification by sequencing, the plasmid
was transformed into BL21 (DE3) cells (Stratagene), and pro-
tein expression was induced by the addition of isopropyl -D-
1-thiogalactopyranoside to 1mM for 3 h at 37 °C. The cell pellet
was lysed using Bugbuster (Novagen) with 25 units of Benzo-
nase/ml and 1 complete protease inhibitors without EDTA
(Roche Applied Science). The lysate was cleared by centrifuga-
tion at 20,000 g and was applied to a column of nickel-nitri-
lotriacetic acid-agarose (Qiagen), followed by extensive wash-
ing of the column with 20 mM imidazole in phosphate buffer
(GE Healthcare). The protein was eluted in 3 column volumes
of phosphate buffer with 0.5 M imidazole. The eluate containing
the His-ELC protein was collected and concentrated using a
Vivaspin 20 concentrator with a 5-kDa molecular mass cut-off
(Sartorius). Buffer exchange into 50mMNaCl, 10mMTris-HCl,
pH 8.0, was carried out using a PD10 column (GE Healthcare).
Biophysical analysis of PfELC and its interaction withMyoA
neck peptides
Peptides—Overlapping peptides representing amino acids
Gln770–Ala787, Ala786–Ser803, and Ile801–Gln818 of the PfMyoA
neck were synthesized by Mimotopes with biotin at the N ter-
minus. Each peptide had an SGSG linker between the biotin
and 18 amino acids of the MyoA neck. The C termini of the
peptides were capped with an amide to remove unnatural
charge, apart from peptide 801–818, which was left as a free
acid.
Far-UV CD—Far-UV CD spectra were recorded on a Jasco
J-815 spectropolarimeter fittedwith a cell holder thermostatted
by a CDF-426S Peltier unit. CD measurements were made at a
protein concentration of 10 M PfELC in 25 mM Tris-HCl, pH
8.0, 50 mM NaCl using fused silica cuvettes with a 1-mm path
length (Hellma). All spectra were recorded with 0.1 nm resolu-
tion and baseline-corrected by subtraction of the buffer spec-
trum. Secondary structure content was estimated using meth-
ods described by Sreerama and Woody (62).
Biolayer interferometry—P. falciparum ELC binding to pep-
tides was analyzed by biolayer interferometry using the Octet
Red system (ForteBio) at 25 °C in 96-well microplates, as
described previously (63). All assays were performed in 100mM
Tris-HCl, pH 8.0, containing 0.005% (v/v) Tween 20, according
to the manufacturer’s instructions. A baseline was established
over 4 min, and biotinylated peptides (0.4 g/ml) were loaded
onto streptavidin sensors for 10 min. The sensors were washed
for 4 min and then incubated with PfELC at different concen-
trations (0.04–5 M) for 800 s. The data were analyzed to cal-
culate a dissociation constant (Kd) using non-linear regression
with a one-site bindingmodel and a least-squares fit (GraphPad
Prism version 6).
In vitro expression and purification of recombinantMyoA
MyoA was expressed in a wheat germ cell-free protein syn-
thesis system (ENDEXT Technology, CellFree Sciences) (64).
Recombinant plasmid DNA using recodonized template DNA
was amplified using specific primers and cloned into the vector
pEU-E01G-TEV-N1 to express N-terminal GST-tagged pro-
tein. For the in vitro transcription reaction, 2 g of DNA was
added to a transcription premix (11.5l of nuclease-free water,
1 transcription buffer, 2.5 mM NTP mix, 1 unit/l RNase
inhibitor, 1 unit/l SP6 RNA polymerase) in a total volume of
20 l and incubated at 37 °C for 6 h, according to the manufa-
cturer’s instructions. The quality ofmRNAproducedwasmon-
itored by gel electrophoresis. The bilayer reaction system (Cell-
Free Sciences) was used to translate mRNA into protein.
mRNA (10 l) was added to 10 l of wheat germ extract
(WEPRO 1240) supplemented with 40 ng/l creatine kinase
and carefully transferred directly below the SUB-AMIX solu-
tion (0.3 mM of each L-amino acid, 100 mM potassium acetate,
2.7 mM magnesium acetate, 16 mM disodium creatine phos-
phate, 0.4 mM spermidine, 1.2 mM ATP, 0.25 mM GTP, 4 mM
dithiothreitol, and 30 mM HEPES-KOH (pH 7.8)) and incu-
bated for 20 h at 15–16 °C. SolubleGST-taggedMyoAwas puri-
fied using glutathione-Sepharose beads (GE Healthcare);
supernatant was incubated with the resin for 2 h at 4 °C, fol-
lowed by extensive washing with 20 mM Tris-HCl, pH 8.0, 250
mM NaCl, 0.5 mM TCEP. The beads were resuspended in 3
volumes of 20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 10 mM
reduced glutathione to elute the GST-tagged protein. This was
followed by buffer exchange into PBS on a PD10 column (GE
Healthcare).
Single-molecule optical tweezer studies to examine theMyoA
interaction with actin
The optical tweezer assay, developed to measure the force
andmovement produced by individualmyosinmolecules inter-
acting with an actin filament, was used in the well-established
three-bead format with the experimental conditions as de-
scribed (65–67). The experimental apparatus is based around a
Zeiss invertedmicroscope, and experiments were performed in
a flow-cell chamber created using a microscope slide and cov-
erslip. The solution buffers and other conditions were identical
to those used in earlier studies (67). A single, rhodamine-phal-
loidin labeled, actin filament, comprising 1:5 biotin-labeled
actin to plain actin, was captured between two neutravidin-
coated beads (1-m diameter) using the dual-beam optical
tweezers. A third, surface-immobilized bead that was sparsely
coatedwithMyoAwas thenpositioned in close proximity to the
actin filament. Interactions between the surface-bound MyoA
and the actin filament were recorded bymonitoringmovement
of the beads held in the optical tweezers using two 4-quadrant,
photodiode detectors. To facilitate visualization, the beads
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were moved backward and forward using a 100-nm amplitude,
10-Hz triangular wave. Individual events were then automati-
cally detected by measuring changes in amplitude of the
imposed triangular oscillation, and event amplitudes were his-
togrammed. Data were acquired and saved to computer mem-
ory using custom software, with a sampling rate of 10 kHz, and
later analyzed using IgorPro software (WaveMetrics Inc., Lake
Oswego, OR). Individual acto-MyoA force-producing events
were identified as described previously (65), and the MyoA
power-stroke amplitude and kinetics were analyzed by histo-
gram analysis of the data.
Expression in insect cells and purification of recombinant
MyoAwith light chains
Following the example of Bookwalter et al. (15), we co-ex-
pressed PfHsp90 and Unc45 chaperones together with full-
length MyoA, PfELC, and MTIP in Sf21 cells. By sequence ho-
mology, PF3D7_1420200 is the P. falciparum orthologue of
Toxoplasma Unc45 (http://plasmodb.org/plasmo/).9 Codon-
optimized genes were designed and synthesized (Life Technol-
ogies) for insect cell expression. A codon-optimized Hsp90
(PF3D7_0708400) was a kind gift from Dr. Will Stanley.
PfUnc45was cloned under the polyhedrin promoter in the pFL
vector (68) andHsp90 under the control of the p10 promoter in
the same vector. MyoA (PF3D7_1342600) was cloned into the
pFL vector and fusedwithN-terminal StrepTagII and gfp under
the polyhedrin promoter. MTIP (PF3D7_1246400) and ELC
(PF3D7_1017500) genes were cloned into the pFL vectors
under the control of the polyhedrin promoter with N-terminal
hexahistidine tags. Each construct was transformed in MAX
Efficiency DH10Bac cells (Invitrogen), bacmids were isolated,
and the gene integrations were confirmed using standard pro-
tocols (Bac-to-Bac, Invitrogen). Sf21 cells (Gibco) were trans-
fected using FuGene 6 (Promega) as described (69). After two
rounds of virus amplification, Sf21 cells were co-infected with
untitered recombinant viruses in ratios of 0.75:1:1:1 for MyoA/
Unc45/MTIP/ELC or 0.75:1:1 for MyoA/Unc45/MTIP, and
cells were harvested 3 days postinfection. We used 1.5 ml of
MyoA-expressing virus per 1 108 cells, and for the others we
used 2 ml per 1  108 cells. Cells were collected, washed with
PBS, resuspended in the lysis buffer (20 mM Hepes, pH 7.5, 5%
trehalose dihydrate (w/v), 1 mM ATP, 0.5 mM TCEP, 2.5 mM
MgCl2, 0.5 mg of avidin, 1 SigmaFast EDTA-free protease
inhibitor), sonicated, and clarified at 38,000  g. Remaining
supernatant was applied into two interconnected 1-ml Strep-
Tactin superflow columns (IBA GmbH), washed with lysis
buffer, washing buffer 1 (20 mM Hepes, pH 7.5, 5% trehalose
dihydrate (w/v), 150 mM KCl, 0.5 mM TCEP), and washing
buffer 2 (20mMHepes, pH7.5, 5% trehalose dihydrate (w/v), 0.5
mM TCEP). MyoA complexes were eluted with 20 mM Hepes,
pH 7.5, 5% trehalose dihydrate (w/v), 0.5mMTCEP, and 3.5mM
D-desthiobiotin. MyoA light chain–containing fractions were
pooled, concentrated, and run over a Superdex 200 increase
10/300GL column (GE Healthcare) in washing buffer 2. After a
size-exclusion step, fractions containing MyoA-light chain
complexes were pooled, concentrated, snap-frozen in liquid
N2, and stored at
76 °C until use.
In vitromotility assays
Motility assays were essentially performed as in Butt et al.
(70). Our assay buffer, AB (25mM imidazole-HCl, 25mMKCl, 1
mM EGTA, 4 mM MgCl2, pH 7.4) was repeatedly degassed and
flushed with argon and stored in a hypodermic syringe to pre-
vent oxygen contamination. An oxygen scavenger, COG (20
mM DTT, 0.2 mg/ml glucose oxidase, 0.5 mg/ml catalase, 3
mg/ml glucose, 0.5 mg/ml BSA) was added to buffers used dur-
ing fluorescence imaging and stored at room temperature dur-
ing experiments. Microscope flow-cell chambers were con-
structed using double-sided tape (Tesa), and flow-cell volume
was 8–12 l. To capture MyoA-light chain complexes by
anti-His antibody, nitrocellulose-coated coverslips were incu-
bated with neutravidin (Thermo Fisher Scientific) for 4 min.
The flow chamber was then washed four times with buffer AB
and then blocked (twice) with AB/BSA (AB with 0.5 mg/ml
BSA) for 2 min. Biotinylated anti-His antibody (Qiagen) was
diluted 1:5 in AB/BSA and applied into the flow cell for 4 min.
The non-bound antibodies were removed by washing twice
with AB/BSA, and MyoA complexes were applied for 2 min,
before washing the flow cell twice with AB/BSA and applying
rhodamine-phalloidin–labeled F-actin in AB/COG for 2 min.
We used MyoA-MTIP and MyoA-MTIP-PfELC at concentra-
tions of 0.25 and 0.27mg/ml for nitrocellulose capture and 0.11
and 0.05 mg/ml for anti-His tag capture, respectively. The flow
cell was washed twice with AB/COG and then viewed by fluo-
rescence microscopy. Assays were performed using an Axios-
kop 40 fluorescence microscope with a Zeiss PlanNeofluar
100, 1.3 numeric aperture objective lens. Fluorescence was
excited by amercury arc lampusing a rhodamine filter set (exci-
tation filter HQ535/50, dichroic mirror Q565LP, and emission
filter HQ605/75; Chroma Technology), and light emitted from
the rhodamine-phalloidin–labeled actin filament specimen
was imaged onto an image-intensified charge-coupled device
camera (IC-310, Photon Technology International), where, at
the magnification used, each pixel corresponded to 100 nm at
the object plane. Sequences of video frames were captured
every 40ms using a frame grabber card (Multipix Imaging Ltd.).
The laboratory was air-conditioned, and the experimental tem-
perature was kept at 23 °C. Filament specimens were tracked
automatically with GMimPro (71) using non-default settings
Q-threshold 3 and track length 5 after saving each image
sequence as a median of five consecutive image blocks. Non-
motile or short trackswere removedmanually. From the result-
ing average velocities, frequency distribution histograms were
calculated (a bin size of 0.02), and a Gaussian curve was fitted
with GraphPad Prism version 7.
Actin-activated ATPase assay
The actin-activated ATPase of MyoA-MTIP and MyoA-
MTIP-PfELC was estimated using an NADH-coupled assay to
quantify the rate of ATP hydrolysis. The assay buffer contained
160 units/ml lactate dehydrogenase, 400 units/ml pyruvate
kinase, 1mM phospho(enol) pyruvate, 0.5mMATP, and 0.3mM
NADH in the motility assay buffer, AB. The myosins (MyoA-
MTIP orMyoA-MTIP-PfELC)were added to a final concentra-
tion of 0.13M, and phalloidin-stabilized filamentous actin was
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added over the range of 7–130 M. The rate of ATP hydrolysis
was calculated from the rate of change in NADH absorbance
measured in a temperature-controlled spectrophotometer at
340 nm. Experiments were conducted at 23 °C. The data were
fit to the Michaelis–Menten equation using non-linear regres-
sion with a least-squares fit in GraphPad Prism.
Primers
Sequences of primers used in these studies are available on
request.
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